Functional analysis of the dCAMTA Transcription factor

dCAMTA 转录因子的功能分析

基本信息

  • 批准号:
    6674712
  • 负责人:
  • 金额:
    $ 38.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-08-01 至 2008-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term goal of the proposed research is to understand how calcium, a universal messenger, regulates gene expression and cell activities. Calcium ions are pivotal in the regulation of a variety of cellular processes. Abnormal calcium homeostasis has been implicated in aging and in numerous human diseases, such as Alzheimer's disease. The enduring regulatory effects of calcium depend on changes in gene expression. The mechanisms by which cells decode the information carried by calcium signals and convert them into distinct alterations in gene expression is poorly understood. A prevailing model is that Ca2+ entry through different ion channels activates distinct transcription factors. Through the mediation of a series of protein kinases or phosphatases, Ca2+/calmodulin stimulates a range of transcription factors. Recent bioinformatic analyses have suggested the existence of transcription factors that are activated directly by Ca2+/calmodulin, which could respond to Ca2+ signals more quickly. A group of candidates, the calmodulin-binding transcription activators (CAMTAs) were recently identified in plants. Their homologs in animals have yet to be studied. We have isolated two Drosophila mutant alleles of dCAMTA, the fly CAMTA gene, and detected a strong and consistent phenotype in these mutants that implies an impaired deactivation of the fly light-stimulated Ca2+ channel TRP. Therefore we plan to use the fly photoreceptor cells as an assay system to study this new group of Ca2+-regulated transcription factors. A combination of molecular and cell biological, genetic, electrophysiological and calcium imaging approaches will be used to: 1. Test the hypothesis that dCAMTA is activated through Ca2+/calmodulin-binding in vivo. 2: Test the hypothesis that dCAMTA exists in the cytoplasm and translocates into the nuclei upon activation. 3: Test the hypothesis that dCAMTA proteins form homomultimers. 4. Test the hypothesis that dCAMTA depends on TRP channels for activation in the photoreceptor cells. 5. Test the hypothesis that the loss of dCAMTA function leads to increased Ca2+ level in the photoreceptor cells. 6. Determine the target genes of dCAMTA.
描述(由申请人提供):拟议研究的长期目标是了解钙这种通用信使是如何调节基因表达和细胞活动的。钙离子在调节多种细胞过程中起着关键作用。钙稳态异常与衰老和许多人类疾病有关,如阿尔茨海默病。钙的持久调节作用取决于基因表达的变化。细胞对钙信号携带的信息进行解码并将其转化为基因表达的明显变化的机制尚不清楚。一种流行的模型是,钙离子通过不同的离子通道进入激活不同的转录因子。通过一系列蛋白激酶或磷酸酶的调节,钙/钙调蛋白刺激一系列转录因子。最近的生物信息学分析表明,存在由钙/钙调蛋白直接激活的转录因子,它们可以更快地对钙信号做出反应。最近在植物中发现了一组候选基因,即钙调蛋白结合转录激活因子(CAMTA)。它们在动物中的同源物还有待研究。我们已经分离了果蝇dCAMTA的两个突变等位基因,即苍蝇CAMTA基因,并在这些突变体中检测到一个强烈而一致的表型,表明苍蝇光刺激的钙通道Trp的失活受到损害。因此,我们计划利用苍蝇光感受器细胞作为检测系统来研究这组新的钙调控转录因子。将结合分子和细胞生物学、遗传学、电生理学和钙成像方法:1.在体内验证dCAMTA通过钙/钙调素结合而激活的假说。2:验证dCAMTA存在于细胞质中并在激活时移位到细胞核的假设。3:检验dCAMTA蛋白形成同源多聚体的假设。4.验证光感受器细胞中dCAMTA依赖Trp通道激活的假设。5.验证dCAMTA功能丧失导致感光细胞内钙离子水平升高的假说。6.确定dCAMTA的靶基因。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HONG-SHENG LI其他文献

HONG-SHENG LI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HONG-SHENG LI', 18)}}的其他基金

Neuron-glia interactions in Drosophila visual neuropiles
果蝇视觉神经桩中神经元-胶质细胞的相互作用
  • 批准号:
    9767199
  • 财政年份:
    2017
  • 资助金额:
    $ 38.23万
  • 项目类别:
Neuron-glia interactions in Drosphila visual neuropiles
果蝇视觉神经桩中神经元-胶质细胞的相互作用
  • 批准号:
    8444403
  • 财政年份:
    2012
  • 资助金额:
    $ 38.23万
  • 项目类别:
Neuron-glia interactions in Drosphila visual neuropiles
果蝇视觉神经桩中神经元-胶质细胞的相互作用
  • 批准号:
    8297861
  • 财政年份:
    2012
  • 资助金额:
    $ 38.23万
  • 项目类别:
Rhodopsin endocytic trafficking and Drosophila visual sensitivity
视紫红质内吞运输和果蝇视觉敏感性
  • 批准号:
    7655835
  • 财政年份:
    2009
  • 资助金额:
    $ 38.23万
  • 项目类别:
Rhodopsin endocytic trafficking and Drosophila visual sensitivity
视紫红质内吞运输和果蝇视觉敏感性
  • 批准号:
    7895552
  • 财政年份:
    2009
  • 资助金额:
    $ 38.23万
  • 项目类别:
Functional analysis of the dCAMTA Transcription factor
dCAMTA 转录因子的功能分析
  • 批准号:
    7681859
  • 财政年份:
    2003
  • 资助金额:
    $ 38.23万
  • 项目类别:
Functional analysis of the dCAMTA Transcription factor
dCAMTA 转录因子的功能分析
  • 批准号:
    6780865
  • 财政年份:
    2003
  • 资助金额:
    $ 38.23万
  • 项目类别:
Functional analysis of the dCAMTA Transcription factor
dCAMTA 转录因子的功能分析
  • 批准号:
    7268696
  • 财政年份:
    2003
  • 资助金额:
    $ 38.23万
  • 项目类别:
Functional analysis of the CAMTA Transcription Factors
CAMTA转录因子的功能分析
  • 批准号:
    8318632
  • 财政年份:
    2003
  • 资助金额:
    $ 38.23万
  • 项目类别:
Functional analysis of the CAMTA Transcription Factors
CAMTA转录因子的功能分析
  • 批准号:
    8520125
  • 财政年份:
    2003
  • 资助金额:
    $ 38.23万
  • 项目类别:

相似海外基金

Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
  • 批准号:
    502607
  • 财政年份:
    2024
  • 资助金额:
    $ 38.23万
  • 项目类别:
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
  • 批准号:
    502578
  • 财政年份:
    2024
  • 资助金额:
    $ 38.23万
  • 项目类别:
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
  • 批准号:
    MR/Y008847/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.23万
  • 项目类别:
    Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
  • 批准号:
    BB/Y002180/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.23万
  • 项目类别:
    Research Grant
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
  • 批准号:
    EP/Y024540/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.23万
  • 项目类别:
    Fellowship
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
  • 批准号:
    24K19237
  • 财政年份:
    2024
  • 资助金额:
    $ 38.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
  • 批准号:
    MR/Y003616/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.23万
  • 项目类别:
    Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
  • 批准号:
    MR/Y033698/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.23万
  • 项目类别:
    Research Grant
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
  • 批准号:
    479128
  • 财政年份:
    2023
  • 资助金额:
    $ 38.23万
  • 项目类别:
    Operating Grants
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
  • 批准号:
    23H03716
  • 财政年份:
    2023
  • 资助金额:
    $ 38.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了